MENU
+Compare
ROIV
Stock ticker: NASDAQ
AS OF
Aug 1 closing price
Price
$11.31
Change
-$0.09 (-0.79%)
Capitalization
7.73B

ROIV Roivant Sciences Ltd Forecast, Technical & Fundamental Analysis

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients... Show more

ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ROIV with price predictions
Aug 01, 2025

ROIV sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for ROIV moved above the 200-day moving average on July 23, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

ROIV moved above its 50-day moving average on July 09, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ROIV crossed bullishly above the 50-day moving average on July 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ROIV advanced for three days, in of 240 cases, the price rose further within the following month. The odds of a continued upward trend are .

ROIV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 158 cases where ROIV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 30, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ROIV as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ROIV turned negative on July 25, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ROIV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ROIV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.648) is normal, around the industry mean (17.448). P/E Ratio (1.966) is within average values for comparable stocks, (58.797). ROIV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.618). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (285.714) is also within normal values, averaging (276.708).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ROIV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ROIV is expected to report earnings to fall 15.07% to -24 cents per share on August 11

Roivant Sciences Ltd ROIV Stock Earnings Reports
Q2'25
Est.
$-0.25
Q1'25
Missed
by $0.03
Q4'24
Beat
by $0.48
Q3'24
Missed
by $0.02
Q2'24
Beat
by $0.36
The last earnings report on May 29 showed earnings per share of -28 cents, missing the estimate of -26 cents. With 2.91M shares outstanding, the current market capitalization sits at 7.73B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
50 Broadway
Phone
+44 2074003347
Employees
904
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IYCEX18.33N/A
N/A
Macquarie Core Equity Fund Class R
PDIFX15.34N/A
N/A
Principal Diversified International R6
NRDGX24.09N/A
N/A
Neuberger Berman Dividend Growth R6
MUOIX32.22N/A
N/A
Morgan Stanley Instl US Core I
CWIAX69.86-0.90
-1.27%
American Funds Capital World Gr&Inc 529A

ROIV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with ACLX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-0.79%
ACLX - ROIV
53%
Loosely correlated
-0.35%
IMVT - ROIV
53%
Loosely correlated
-2.30%
CRNX - ROIV
52%
Loosely correlated
-2.62%
KRYS - ROIV
51%
Loosely correlated
+2.02%
CGON - ROIV
50%
Loosely correlated
-1.42%
More